Publication | Closed Access
Tumor Enhancement and Heterogeneity Are Associated With Treatment Response to Drug-Eluting Bead Chemoembolization for Hepatocellular Carcinoma
25
Citations
18
References
2016
Year
Tumor heterogeneity and enhancement on arterial phase imaging may be predictive markers of treatment response to DEB-TACE among patients with HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1